From October 1, 2023 to October 25, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 11,614,548 shares, representing 1.25% for CNY 402.02 million under the buyback announced on December 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.3 CNY | -0.79% | -0.44% | +15.11% |
14/05 | Livzon Pharmaceutical Group Cancels Share Options | MT |
14/05 | Livzon Pharmaceutical Declares Final Dividend for 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.11% | 4.6B | |
+35.01% | 709B | |
+30.96% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.42% | 239B | |
+9.41% | 211B | |
-4.29% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Tranche Update on Livzon Pharmaceutical Group Inc.'s Equity Buyback Plan announced on December 6, 2022.